Industry NewsPfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize coronavirus mutations
Expert InsightsGene modulation in primary human immune cells: Successful strategies and applications for CRISPRko, RNAi and beyond
Industry NewsRoche receives FDA authorization for semi-quantitative test to measure the level of SARS-CoV-2 antibodies
Expert InsightsCAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma: Your questions answered
Expert InsightsInvestigating traditional and modern approaches to antimicrobial susceptibility testing
Industry NewsOrgenesis, Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies
Industry NewsQIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of the head and neck
Industry NewsThe University of Oxford and Thermo Fisher Scientific ramp up COVID-19 testing capability
Industry NewsRelief, NeuroRx enrolls 150 patients in phase 2b/3 trial of RLF-100 for critical COVID-19 with respiratory failure
Product NewsLonza announces broad selection of high-resolution HLA-typed primary cell lots to support biologic drug research
Product NewsQIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets
Product NewsQIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour
Industry NewsMedicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
